NCT02718105View on ClinicalTrials.gov

Maternal and Fetal Compatibility in Assisted Reproductive Technology (ART)-Oocyte Donor Influences Live Birth Rate

CompletedOBSERVATIONAL

Enrollment

200

Participants

Timeline

Start Date

January 1, 2022

Primary Completion Date

April 1, 2022

Study Completion Date

August 1, 2022

Conditions

Infertility

Interventions

GENETIC

KIR HLAC determinations

We will take blood samples for KIR HLA-C determinations.

Trial Locations (1)

28035

Instituto Valenciano de Infertilidad, Madrid

All Listed Sponsors

lead

IVI Madrid

OTHER

NCT02718105 - Maternal and Fetal Compatibility in Assisted Reproductive Technology (ART)-Oocyte Donor Influences Live Birth Rate | Biotech Hunter | Biotech Hunter